Navigation Links
Ambitious Gastric Cancer Research Project Proposed in Singapore

A S$25 million research project, described as the largest ever in Singapore, will focus on gastric or stomach cancer, it has been announced.

In Singapore, gastric cancer (or stomach cancer) is the 4th most common cancer among men and 6th among women, says the Singapore Cancer Society.

It occurs most frequently in men and women above 40 years old, and is more common in Chinese than Malay or Indian.

There is no scientific conclusion of the actual cause of gastric cancer, people with family history of gastric cancer, high consumption of smoked and salted food, lack of Vitamin C, and existence of a bacterium called Helicobactor Pylori are known to be risk factors of gastric cancer.

If gastric cancer is detected at early stage, it is a curable disease. This makes understanding the nature of gastric cancer, its prevention and early detection essential to reduce the risk of gastric cancer, the society says.

Each year, 600 people are diagnosed with it and 400 die from it.

But these numbers could soon be reduced if the Singapore Gastric Cancer Consortium achieves results through its new five-year research project.

It is bringing together clinicians and researchers from four public hospitals, two universities, and leading research institutes such as the Genome Institute of Singapore.

Says Yong Ying-I, Permanent Secretary, Health Ministry, Co-Chair, Biomedical Science Executive Committee, "Gastric cancer is a major killer and if they are able to bring together different expertise, it will be of great benefit to patientsso this is why the Ministry of Health is extremely excited about this project."

At the National University of Singapore, a cohort study involving 4000 people will hopefully allow researchers to identify bio markers of gastric cancer.

This could mean that in future, the risk of getting gastric cancer can be determined by a blood test.

Currently, many die from the disease because it is detected too late.

Research would hopefully make it easier for patients to be screened early. At the National Cancer Centre, researchers will be looking at cancer-causing genes. With enough information, they could develop personalised treatment plans for different patients with different genes, thereby increasing the chances of survival.

National University Hospital (NUH) is where patients may get to test these cutting edge research techniques, at no cost.

Says Dr Yong Wei Peng, Principal Investigator, Consultant, Cancer Institute at NUH, "We hope to bring in new drugs for patients [for whom] standard treatment has been exhausted. So hopefully for advanced stages of cancer, this group of patients will benefit through availability of new drugs."

The team assures patients that its work is in line with international standards. Says Associate Professor Yeoh Khay Guan, Lead Principal Investigator, Singapore Gastric Cancer Consortium, "We're part of a research programme called the ICBC - the International Cancer Biomarker Consortium [which] links up cancer centres and research groups across the world. It's led by the Fred Hutchinson Cancer Centre in Seattle USA."

The project is the most extensive and well integrated research project in Singapore so far. It is significant because it marks Singapore's entry into Phase Two of the Biomedical Sciences Initiative, which aims to bring research from bench to bedside, to benefit patients.

In the months ahead, another four research projects will be announced in the fields of infectious diseases, eye diseases, cardiovascular disorders, and neurosciences.

S$1.5 billion has been set aside for the second phase of the Biomedical Sciences Initiative, which aims to position Singapore as a leader in scientific and medical research.


'"/>




Related medicine news :

1. The Reason For Loss Of Appetite After Gastric Bypass
2. Gastric bypass surgery reduces risk of heart disease
3. Surgeons Perform Robotic Gastric Bypass Surgery
4. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
5. New Gastric Cancer Drug Unlikely to Benefit Kidney Cancer Patients
6. Migraine Patients Suffer From Gastric Stasis
7. Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity
8. Gastric bypass can cause deficiency of Vitamin A
9. For Super-Obese Patients, Duodenal Switch Beats Gastric Bypass
10. Long-time Gastric Acid Suppression Does Not Increase The Risk Of Cancer
11. Gastric Bypass Surgery May Lead to Increased Kidney Stone Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... Florida (PRWEB) , ... January 19, 2017 , ... ... dollar 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located ... meet the growing demand of physicians and patients throughout the United States for ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will be co-hosting a ... innovative excipients and drug delivery solutions to health industries worldwide. The one day ...
(Date:1/19/2017)... ... January 19, 2017 , ... In ... administered fillers that resulted in severe facial disfiguration. After four frightening years of ... doctors at UCLA Medical Center, who removed the substances in a partial facial ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) is ... passionate about making a difference in the lives of the next generation of ... nonprofit healthcare educational institution, has more than 30,000 alumni and employs more than ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... BOCA RATON, Fla. , Jan. 19, 2017 ... ), a medical device company specializing in the ... conditions, such as keloids, with superficial radiation therapy, ... quarter and full year 2016 financial results on Thursday, ... The Company will hold a conference call ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
Breaking Medicine Technology: